Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Targeting Cellular Senescence With Fisetin for Improving Vascular Endothelial Function in Older Adults

Authors not listed

University of Colorado, Boulder · 2026

Abstract

Aging is associated with the development of vascular dysfunction, which increases the risk for cardiovascular disease. This clinical trial will assess if supplementation with the natural compound fisetin can improve vascular endothelial function in older adults. The clinical trial will also assess if any effects of fisetin on endothelial function are associated with reduced cellular senescence(definition). The study will also evaluate safety, tolerability and adherence with fisetin treatment.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-10 MST

Cite this

APA
Anonymous. (2026). Targeting Cellular Senescence With Fisetin for Improving Vascular Endothelial Function in Older Adults. <em>University of Colorado, Boulder</em>. https://clinicaltrials.gov/study/NCT07871162
Vancouver
Anonymous. Targeting Cellular Senescence With Fisetin for Improving Vascular Endothelial Function in Older Adults. University of Colorado, Boulder. 2026.
BibTeX
@misc{anon2026Target, title = {Targeting Cellular Senescence With Fisetin for Improving Vascular Endothelial Function in Older Adults}, author = {Anonymous}, journal = {University of Colorado, Boulder}, year = {2026}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings